|
|
Previous Article | Table of Contents | Next Article 
Blood, 1 August 2001, Vol. 98, No. 3, pp. 787-794
NEOPLASIA
Altered apoptosis pathways in mantle cell lymphoma detected by
oligonucleotide microarray
Wolf-K. Hofmann,
Sven de Vos,
Kunihiro Tsukasaki,
William Wachsman,
Geraldine S. Pinkus,
Jonathan W. Said, and
H. Phillip Koeffler
An imbalance between cellular apoptosis and survival may be
critical for the pathogenesis of lymphoma. Therefore, the gene expression pattern in lymph node preparations from patients with mantle
cell lymphoma (MCL) was compared to the pattern in nonmalignant hyperplastic lymph nodes (HLs). Oligonucleotide microarray analysis was
performed comparing 5 MCLs to 4 HLs using high-density microarrays. The
expression data were analyzed using Genespring software. For confirmation, the expression of selected genes was analyzed by real-time polymerase chain reaction using the RNA extracted from 16 MCL
and 12 HL samples. The focus was on 42 genes that were at least 3-fold
down-regulated in MCL; in addition to the B-cell leukemia 2 (BCL2)
system other apoptotic pathways were altered in MCL. The FAS-associated
via death domain (FADD) gene that acts downstream of the
FAS cascade as a key gene to induce apoptosis was more than 10-fold
down-regulated in MCL. Furthermore, the death-associated protein 6 (DAXX) gene, the caspase 2 (CASP2) gene, and
the RIPK1 domain containing adapter with death domain (RAIDD) gene, which are key genes in other proapoptotic
pathways, were also decreased in the MCL samples. The suggestion is
made that in addition to the known overexpression of cyclin D1, which drives entry into the cell cycle, disturbances of pathways associated with apoptosis contribute to the development of MCL.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
Q. Lan, L. M. Morton, B. Armstrong, P. Hartge, I. Menashe, T. Zheng, M. P. Purdue, J. R. Cerhan, Y. Zhang, A. Grulich, et al.
Genetic variation in caspase genes and risk of non-Hodgkin lymphoma: a pooled analysis of 3 population-based case-control studies
Blood,
July 9, 2009;
114(2):
264 - 267.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. H. Ho, R. Taylor, L. Dorstyn, D. Cakouros, P. Bouillet, and S. Kumar
A tumor suppressor function for caspase-2
PNAS,
March 31, 2009;
106(13):
5336 - 5341.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Gelebart, M. Anand, H. Armanious, A. C. Peters, J. Dien Bard, H. M. Amin, and R. Lai
Constitutive activation of the Wnt canonical pathway in mantle cell lymphoma
Blood,
December 15, 2008;
112(13):
5171 - 5179.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. A. Tucker, A. I. Kapanen, G. Chikh, B. G. Hoffman, A. H. Kyle, I. M. Wilson, D. Masin, R. D. Gascoyne, M. Bally, and R. J. Klasa
Silencing Bcl-2 in models of mantle cell lymphoma is associated with decreases in cyclin D1, nuclear factor-{kappa}B, p53, bax, and p27 levels
Mol. Cancer Ther.,
April 1, 2008;
7(4):
749 - 758.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Kawamata, J. Chen, and H. P. Koeffler
Suberoylanilide hydroxamic acid (SAHA; vorinostat) suppresses translation of cyclin D1 in mantle cell lymphoma cells
Blood,
October 1, 2007;
110(7):
2667 - 2673.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Elmore
Apoptosis: A Review of Programmed Cell Death
Toxicol Pathol,
June 1, 2007;
35(4):
495 - 516.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Perez-Galan, G. Roue, N. Villamor, E. Campo, and D. Colomer
The BH3-mimetic GX15-070 synergizes with bortezomib in mantle cell lymphoma by enhancing Noxa-mediated activation of Bak
Blood,
May 15, 2007;
109(10):
4441 - 4449.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
O. A. O'Connor
Mantle Cell Lymphoma: Identifying Novel Molecular Targets in Growth and Survival Pathways
Hematology,
January 1, 2007;
2007(1):
270 - 276.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Rudelius, S. Pittaluga, S. Nishizuka, T. H.-T. Pham, F. Fend, E. S. Jaffe, L. Quintanilla-Martinez, and M. Raffeld
Constitutive activation of Akt contributes to the pathogenesis and survival of mantle cell lymphoma
Blood,
September 1, 2006;
108(5):
1668 - 1676.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Ek, U. Andreasson, S. Hober, C. Kampf, F. Ponten, M. Uhlen, H. Merz, and C. A. K. Borrebaeck
From Gene Expression Analysis to Tissue Microarrays: A Rational Approach to Identify Therapeutic and Diagnostic Targets in Lymphoid Malignancies
Mol. Cell. Proteomics,
June 1, 2006;
5(6):
1072 - 1081.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Ikezoe, S. Gery, D. Yin, J. O'Kelly, L. Binderup, N. Lemp, H. Taguchi, and H. P. Koeffler
CCAAT/Enhancer-Binding Protein {delta}: A Molecular Target of 1,25-Dihydroxyvitamin D3 in Androgen-Responsive Prostate Cancer LNCaP Cells
Cancer Res.,
June 1, 2005;
65(11):
4762 - 4768.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Dernbach, C. Urbich, R. P. Brandes, W. K. Hofmann, A. M. Zeiher, and S. Dimmeler
Antioxidative stress-associated genes in circulating progenitor cells: evidence for enhanced resistance against oxidative stress
Blood,
December 1, 2004;
104(12):
3591 - 3597.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. J. de Leeuw, J. J. Davies, A. Rosenwald, G. Bebb, R. D. Gascoyne, M. J.S. Dyer, L. M. Staudt, J. A. Martinez-Climent, and W. L. Lam
Comprehensive whole genome array CGH profiling of mantle cell lymphoma model genomes
Hum. Mol. Genet.,
September 1, 2004;
13(17):
1827 - 1837.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. M. Dring, F. E. Davies, J. A. L. Fenton, P. L. Roddam, K. Scott, D. Gonzalez, S. Rollinson, A. C. Rawstron, K. S. Rees-Unwin, C. Li, et al.
A Global Expression-based Analysis of the Consequences of the t(4;14) Translocation in Myeloma
Clin. Cancer Res.,
September 1, 2004;
10(17):
5692 - 5701.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. L. Ebert and T. R. Golub
Genomic approaches to hematologic malignancies
Blood,
August 15, 2004;
104(4):
923 - 932.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Zettl, T. Rudiger, M.-A. Konrad, A. Chott, I. Simonitsch-Klupp, R. Sonnen, H. K. Muller-Hermelink, and G. Ott
Genomic Profiling of Peripheral T-Cell Lymphoma, Unspecified, and Anaplastic Large T-Cell Lymphoma Delineates Novel Recurrent Chromosomal Alterations
Am. J. Pathol.,
May 1, 2004;
164(5):
1837 - 1848.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Thieblemont, V. Nasser, P. Felman, K. Leroy, S. Gazzo, E. Callet-Bauchu, B. Loriod, S. Granjeaud, P. Gaulard, C. Haioun, et al.
Small lymphocytic lymphoma, marginal zone B-cell lymphoma, and mantle cell lymphoma exhibit distinct gene-expression profiles allowing molecular diagnosis
Blood,
April 1, 2004;
103(7):
2727 - 2737.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Martinez, F. I. Camacho, P. Algara, A. Rodriguez, A. Dopazo, E. Ruiz-Ballesteros, P. Martin, J. A. Martinez-Climent, J. Garcia-Conde, J. Menarguez, et al.
The Molecular Signature of Mantle Cell Lymphoma Reveals Multiple Signals Favoring Cell Survival
Cancer Res.,
December 1, 2003;
63(23):
8226 - 8232.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. J. Park, P. T. Vuong, S. de Vos, D. Douer, and H. P. Koeffler
Comparative analysis of genes regulated by PML/RAR{alpha} and PLZF/RAR{alpha} in response to retinoic acid using oligonucleotide arrays
Blood,
November 15, 2003;
102(10):
3727 - 3736.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L.-Y. Chen and J. D. Chen
Daxx Silencing Sensitizes Cells to Multiple Apoptotic Pathways
Mol. Cell. Biol.,
October 15, 2003;
23(20):
7108 - 7121.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Greil, G. Anether, K. Johrer, and I. Tinhofer
Tracking death dealing by Fas and TRAIL in lymphatic neoplastic disorders: pathways, targets, and therapeutic tools
J. Leukoc. Biol.,
September 1, 2003;
74(3):
311 - 330.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Heeschen, A. Aicher, R. Lehmann, S. Fichtlscherer, M. Vasa, C. Urbich, C. Mildner-Rihm, H. Martin, A. M. Zeiher, and S. Dimmeler
Erythropoietin is a potent physiologic stimulus for endothelial progenitor cell mobilization
Blood,
August 15, 2003;
102(4):
1340 - 1346.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Vallat, H. Magdelenat, H. Merle-Beral, P. Masdehors, G. Potocki de Montalk, F. Davi, M. Kruhoffer, L. Sabatier, T. F. Orntoft, and J. Delic
The resistance of B-CLL cells to DNA damage-induced apoptosis defined by DNA microarrays
Blood,
June 1, 2003;
101(11):
4598 - 4606.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Assmus, C. Urbich, A. Aicher, W. K. Hofmann, J. Haendeler, L. Rossig, I. Spyridopoulos, A. M. Zeiher, and S. Dimmeler
HMG-CoA Reductase Inhibitors Reduce Senescence and Increase Proliferation of Endothelial Progenitor Cells via Regulation of Cell Cycle Regulatory Genes
Circ. Res.,
May 16, 2003;
92(9):
1049 - 1055.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Sanchez-Beato, A. Sanchez-Aguilera, and M. A. Piris
Cell cycle deregulation in B-cell lymphomas
Blood,
February 15, 2003;
101(4):
1220 - 1235.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Ullah, J.-G. Chen, B. Temple, D. C. Boyes, J. M. Alonso, K. R. Davis, J. R. Ecker, and A. M. Jones
The {beta}-Subunit of the Arabidopsis G Protein Negatively Regulates Auxin-Induced Cell Division and Affects Multiple Developmental Processes
PLANT CELL,
February 1, 2003;
15(2):
393 - 409.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W.-K. Hofmann, S. de Vos, M. Komor, D. Hoelzer, W. Wachsman, and H. P. Koeffler
Characterization of gene expression of CD34+ cells from normal and myelodysplastic bone marrow
Blood,
November 15, 2002;
100(10):
3553 - 3560.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. K. M. Kim, Y. Wang, A. Gambotto, Y.-M. Kim, R. Weller, B. S. Zuckerbraun, Y. Hua, S. C. Watkins, and T. R. Billiar
Hepatocyte Fas-associating Death Domain Protein/Mediator of Receptor-induced Toxicity (FADD/MORT1) Levels Increase in Response to Pro-apoptotic Stimuli
J. Biol. Chem.,
October 4, 2002;
277(41):
38855 - 38862.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L Leoncini, S Lazzi, C Bellan, and P Tosi
Cell kinetics and cell cycle regulation in lymphomas
J. Clin. Pathol.,
September 1, 2002;
55(9):
648 - 655.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. S. Robetorye, S. D. Bohling, J. W. Morgan, G. C. Fillmore, M. S. Lim, and K. S. J. Elenitoba-Johnson
Microarray Analysis of B-Cell Lymphoma Cell Lines with the t(14;18)
J. Mol. Diagn.,
August 1, 2002;
4(3):
123 - 136.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Ek, C.-M. Hogerkorp, M. Dictor, M. Ehinger, and C. A. K. Borrebaeck
Mantle Cell Lymphomas Express a Distinct Genetic Signature Affecting Lymphocyte Trafficking and Growth Regulation as Compared with Subpopulations of Normal Human B Cells
Cancer Res.,
August 1, 2002;
62(15):
4398 - 4405.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Schoch, A. Kohlmann, S. Schnittger, B. Brors, M. Dugas, S. Mergenthaler, W. Kern, W. Hiddemann, R. Eils, and T. Haferlach
Acute myeloid leukemias with reciprocal rearrangements can be distinguished by specific gene expression profiles
PNAS,
July 23, 2002;
99(15):
10008 - 10013.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|